Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism - PubMed (original) (raw)
Comparative Study
Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism
Adrian L Oblak et al. J Neurochem. 2010.
Abstract
Autism is a behaviorally defined neurodevelopmental disorder and among its symptoms are disturbances in face and emotional processing. Emerging evidence demonstrates abnormalities in the GABAergic (gamma-aminobutyric acid) system in autism, which likely contributes to these deficits. GABA(B) receptors play an important role in modulating synapses and maintaining the balance of excitation-inhibition in the brain. The density of GABA(B) receptors in subjects with autism and matched controls was quantified in the anterior and posterior cingulate cortex, important for socio-emotional and cognitive processing, and the fusiform gyrus, important for identification of faces and facial expressions. Significant reductions in GABA(B) receptor density were demonstrated in all three regions examined suggesting that alterations in this key inhibitory receptor subtype may contribute to the functional deficits in individuals with autism. Interestingly, the presence of seizure in a subset of autism cases did not have a significant effect on the density of GABA(B) receptors in any of the three regions.
Figures
Figure 1
Pseudocolored image of a control case (1a.) and an autism case (1b.) from the ACC off [3H]-sensitive hyperfilm. The images demonstrate the superficial (I–III) and deep (V–VI) layers that were sampled (1a.) In 1c, a graph demonstrating [3H] labeled GABAB receptor binding density in the anterior cingulate cortex. Each symbol represents the GABAB receptor density from an individual case (see key). There was a significant (**) reductions (p=0.018) in the density of receptors in the autism cases in the superficial layers. Note these are sample sections from individual cases, and although it appears that there is a difference in the deep layers in these cases, statistically there was no significant difference in binding density between autism and control cases.
Figure 2
Pseudocolored images from a control (2a.) and autistic (2b.) case from the PCC. Graphs of the [3H]-CGP54626 labeled GABAB receptor binding density in the posterior cingulate cortex. Significant (**) decreases were found in the superficial (p=0.0076) and deep (p=0.050) layers of the autistic cases when compared to controls.
Figure 3
Graph demonstrating [3H]-CGP54626 labeled GABAB receptor binding density in the fusiform gyrus from a control (3a.) and an autistic case (3b.). Figure 3c is a scatter plot of all cases included in the study. Significant reductions (**) in the superficial (p=0.019) and deep (p=0.00095) layers were found in the autism cases.
Similar articles
- Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism.
Oblak AL, Gibbs TT, Blatt GJ. Oblak AL, et al. Brain Res. 2011 Mar 22;1380:218-28. doi: 10.1016/j.brainres.2010.09.021. Epub 2010 Sep 19. Brain Res. 2011. PMID: 20858465 Free PMC article. - Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism.
Oblak A, Gibbs TT, Blatt GJ. Oblak A, et al. Autism Res. 2009 Aug;2(4):205-19. doi: 10.1002/aur.88. Autism Res. 2009. PMID: 19650112 Free PMC article. - Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism.
Oblak AL, Rosene DL, Kemper TL, Bauman ML, Blatt GJ. Oblak AL, et al. Autism Res. 2011 Jun;4(3):200-11. doi: 10.1002/aur.188. Epub 2011 Feb 28. Autism Res. 2011. PMID: 21360830 Free PMC article. - GHB receptor targets in the CNS: focus on high-affinity binding sites.
Bay T, Eghorn LF, Klein AB, Wellendorph P. Bay T, et al. Biochem Pharmacol. 2014 Jan 15;87(2):220-8. doi: 10.1016/j.bcp.2013.10.028. Epub 2013 Nov 20. Biochem Pharmacol. 2014. PMID: 24269284 Review. - Bridging the cleft at GABA synapses in the brain.
Mody I, De Koninck Y, Otis TS, Soltesz I. Mody I, et al. Trends Neurosci. 1994 Dec;17(12):517-25. doi: 10.1016/0166-2236(94)90155-4. Trends Neurosci. 1994. PMID: 7532336 Review.
Cited by
- Catatonia in autism and other neurodevelopmental disabilities: a state-of-the-art review.
Moore S, Amatya DN, Chu MM, Besterman AD. Moore S, et al. Npj Ment Health Res. 2022 Sep 14;1(1):12. doi: 10.1038/s44184-022-00012-9. Npj Ment Health Res. 2022. PMID: 38609506 Free PMC article. Review. - Fragile X cortex is characterized by decreased parvalbumin-expressing interneurons.
Juarez P, Salcedo-Arellano MJ, Dufour B, Martinez-Cerdeño V. Juarez P, et al. Cereb Cortex. 2024 Mar 1;34(3):bhae103. doi: 10.1093/cercor/bhae103. Cereb Cortex. 2024. PMID: 38521994 - Behavioral and Biochemical Assays for Autism Models of Wistar Rats.
Ukkirapandian K, Elumalai K, Udaykumar KP, Vp S, Rangasmy M. Ukkirapandian K, et al. Cureus. 2024 Jan 10;16(1):e52066. doi: 10.7759/cureus.52066. eCollection 2024 Jan. Cureus. 2024. PMID: 38344592 Free PMC article. - Morphological and Functional Changes of Cerebral Cortex in Autism Spectrum Disorder.
Ong LT, Fan SWD. Ong LT, et al. Innov Clin Neurosci. 2023 Dec 1;20(10-12):40-47. eCollection 2023 Oct-Dec. Innov Clin Neurosci. 2023. PMID: 38193097 Free PMC article. Review. - Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder.
Zarate-Lopez D, Torres-Chávez AL, Gálvez-Contreras AY, Gonzalez-Perez O. Zarate-Lopez D, et al. Curr Neuropharmacol. 2024;22(2):260-289. doi: 10.2174/1570159X22666231003121513. Curr Neuropharmacol. 2024. PMID: 37873949 Free PMC article. Review.
References
- Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P. The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Annals of the New York Academy of Science. 2001;935:107–117. - PubMed
- APA. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Association; 1994.
- Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M, Lantos P. A clinicopathological study of autism. Brain. 1998;121 ( Pt 5):889–905. - PubMed
- Bauman M, Kemper TL. Histoanatomic observations of the brain in early infantile autism. Neurology. 1985;35(6):866–874. - PubMed
- Blatt GJ, Soghomonian JJ, Yip J. Glutamic acid decarboxylase (GAD) as a biomarker of GABAergic activity in autism: impact on cerebellar circuitry and function. In: Blatt GJ, editor. The Neurochemical Basis of Autism: From Molecules to Minicolums. Springer; New York, Dordrecht, Heidelberg, London: 2010.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources